244 results on '"Silvestri, Gerard A"'
Search Results
2. Evaluating the accuracy of lung-RADS score extraction from radiology reports: Manual entry versus natural language processing
3. The Cost-Effectiveness of Nicotine Replacement Therapy Sampling in Primary Care: a Markov Cohort Simulation Model
4. Navigational Bronchoscopy versus Computed Tomography-guided Transthoracic Needle Biopsy for the Diagnosis of Indeterminate Lung Nodules: protocol and rationale for the VERITAS multicenter randomized trial
5. “Randomized trial of physical activity on quality of life and lung cancer biomarkers in patients with advanced stage lung cancer: a pilot study”
6. Abstract 5434: Machine-learning-based epigenetic detection of early-stage lung cancers using the EpiCheck liquid biopsy platform
7. Acquiring tissue for advanced lung cancer diagnosis and comprehensive biomarker testing: A National Lung Cancer Roundtable best‐practice guide
8. A predictive model for lung cancer screening nonadherence in a community setting health-care network
9. Stakeholder Research Priorities for Smoking Cessation Interventions within Lung Cancer Screening Programs. An Official American Thoracic Society Research Statement
10. Evaluating Molecular Biomarkers for the Early Detection of Lung Cancer: When Is a Biomarker Ready for Clinical Use? An Official American Thoracic Society Policy Statement
11. Personalised Lung Cancer Screening (PLuS) study to assess the importance of coexisting chronic conditions to clinical practice and policy: protocol for a multicentre observational study
12. Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease
13. Estimating the Effect of Individual Time Preferences on the Use of Disease Screening
14. The changing epidemiology of lung cancer with a focus on screening
15. Defining comprehensive biomarker‐related testing and treatment practices for advanced non‐small‐cell lung cancer: Results of a survey of U.S. oncologists
16. Lung Cancer Screening Eligibility and Screening Patterns Among Black and White Adults in the United States
17. The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial
18. Whatʼs in a Number? When It Comes to Pulmonary Nodules, Itʼs All About the Number
19. Racial Differences in Outcomes within the National Lung Screening Trial. Implications for Widespread Implementation
20. Increasing Physical Activity and Exercise in Lung Cancer: Reviewing Safety, Benefits, and Application
21. Reply: Lung Cancer Screening: The Balance between Harm and Benefit
22. Screening for Lung Cancer Using Low-Dose Computed Tomography: Are We Headed for DANTEʼs Paradise or Inferno?
23. Lung Cancer Screening
24. Preferences for Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer: Descriptive Study Based on Scripted Interviews
25. Variation in Experts’ Beliefs about Lung Cancer Growth, Progression, and Prognosis
26. Underuse of Surgical Resection for Localized, Non–Small Cell Lung Cancer Among Whites and African Americans in South Carolina
27. Reducing Disparities in Lung Cancer Screening: It’s Not So Black and White
28. A 69-Year-Old With Lung Mass and Mediastinal Lymphadenopathy on Chest Computed Tomography
29. State Variation in Low-Dose Computed Tomography Scanning for Lung Cancer Screening in the United States
30. Invited Commentary: The Etiology of Lung Cancer in Men Compared With Women
31. Defining comprehensive biomarker‐related testing and treatment practices for advanced non‐small‐cell lung cancer: Results of a survey of U.S. oncologists.
32. Conformal High Dose External Radiation Therapy, 80.5 Gy, Alone for Medically Inoperable Non-small Cell Lung Cancer: A Retrospective Analysis
33. Physician Preferences for Management of Patients with Stage IIIA NSCLC: Impact of Bulk of Nodal Disease on Therapy Selection
34. Mediastinal Lymphadenopathy in Patients Undergoing Cardiac Transplant Evaluation
35. You Just Canʼt Call it Lung Cancer Anymore
36. Updates Regarding Biomarker Testing for Non–Small Cell Lung Cancer: Considerations from the National Lung Cancer Roundtable
37. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report
38. An institution-wide faculty mentoring program at an academic health center with 6-year prospective outcome data – ADDENDUM
39. An institution-wide faculty mentoring program at an academic health center with 6-year prospective outcome data
40. Commentary: Invasive mediastinal staging for lung cancer—Quality gap, evidence gap, both?
41. An up to date look at lung cancer screening
42. A Seismic Shift in Staging
43. Boys (and Girls) and Their Toys: A Look at New Technologies in the Bronchoscopy Suite
44. Successful Real-Time Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration of a Hilar Lung Mass Obtained by Traversing the Pulmonary Artery
45. One Hundred Years of Lung Cancer
46. State Variation in Low-Dose Computed Tomography Scanning for Lung Cancer Screening in the United States.
47. Results of the American College of Surgeons Oncology Group Z0050 Trial: The utility of positron emission tomography in staging potentially operable non–small cell lung cancer
48. Detection of Telomerase Expression in Mediastinal Lymph Nodes of Patients with Lung Cancer
49. CT Screening for Lung Cancer: Is Smaller Better?
50. Lunx Is a Superior Molecular Marker for Detection of Non-Small Lung Cell Cancer in Peripheral Blood
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.